These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 31337950

  • 1. Impact of matrix metalloproteinase-11 gene polymorphisms on development and clinicopathologcial variables of uterine cervical cancer in Taiwanese women.
    Ng SC, Wang PH, Lee YC, Lee CY, Yang SF, Shen HP, Hsiao YH.
    Int J Med Sci; 2019; 16(6):774-782. PubMed ID: 31337950
    [Abstract] [Full Text] [Related]

  • 2. Impact of CD44 genetic variants on clinicopathological characteristics of uterine cervical cancer patients.
    Sun YH, Wang CM, Shen HP, Lee CY, Lin CW, Yang SF, Wang PH.
    Int J Med Sci; 2024; 21(8):1428-1437. PubMed ID: 38903932
    [Abstract] [Full Text] [Related]

  • 3. The impact of Aurora kinase A genetic polymorphisms on cervical cancer progression and clinicopathologic characteristics.
    Wu PJ, Wang CH, Hsieh MH, Lee CY, Wang PH, Lin CW, Yang SF, Lee MS.
    Int J Med Sci; 2021; 18(11):2457-2465. PubMed ID: 33967624
    [Abstract] [Full Text] [Related]

  • 4. Impact of pentraxin 3 genetic variants on uterine cervical cancer clinicopathologic characteristics.
    Sun YH, Chou YH, Wang CH, Hsiao YH, Lee CY, Yang SF, Wang PH.
    Int J Med Sci; 2021; 18(11):2339-2346. PubMed ID: 33967610
    [Abstract] [Full Text] [Related]

  • 5. Investigation of metastasis-associated in colon cancer-1 genetic variants in the development and clinicopathologcial characteristics of uterine cervical cancer in Taiwanese women.
    Sun YH, Chou YH, Ou CC, Ng SC, Shen HP, Lee YC, Hsu CF, Yang SF, Wang PH.
    Int J Med Sci; 2020; 17(4):490-497. PubMed ID: 32174779
    [Abstract] [Full Text] [Related]

  • 6. Impact of Matrix Metalloproteinases 11 Gene Variants on Urothelial Cell Carcinoma Development and Clinical Characteristics.
    Li CC, Hsieh MJ, Wang SS, Hung SC, Lin CY, Kuo CW, Yang SF, Chou YE.
    Int J Environ Res Public Health; 2020 Jan 11; 17(2):. PubMed ID: 31940762
    [Abstract] [Full Text] [Related]

  • 7. Impact of matrix metalloproteinase-11 gene polymorphisms upon the development and progression of hepatocellular carcinoma.
    Wang B, Hsu CJ, Lee HL, Chou CH, Su CM, Yang SF, Tang CH.
    Int J Med Sci; 2018 Jan 11; 15(6):653-658. PubMed ID: 29725257
    [Abstract] [Full Text] [Related]

  • 8. The Impact of Matrix Metalloproteinase-11 Polymorphisms on Colorectal Cancer Progression and Clinicopathological Characteristics.
    Huang HC, Shiu BH, Su SC, Huang CC, Ting WC, Chang LC, Yang SF, Chou YE.
    Diagnostics (Basel); 2022 Jul 11; 12(7):. PubMed ID: 35885589
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Relationships of single nucleotide polymorphisms of monocyte chemoattractant protein 1 and chemokine receptor 2 with susceptibility and clinicopathologic characteristics of neoplasia of uterine cervix in Taiwan women.
    Wu HH, Lee TH, Tee YT, Chen SC, Yang SF, Lee SK, Ko JL, Wang PH.
    Reprod Sci; 2013 Oct 11; 20(10):1175-83. PubMed ID: 23427179
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Matrix metalloproteinase 1 gene polymorphism as a prognostic predictor of invasive cervical cancer.
    Lai HC, Chu CM, Lin YW, Chang CC, Nieh S, Yu MH, Chu TY.
    Gynecol Oncol; 2005 Feb 11; 96(2):314-9. PubMed ID: 15661214
    [Abstract] [Full Text] [Related]

  • 13. Effect of tissue inhibitor of metalloproteinases-3 genetics polymorphism on clinicopathological characteristics of uterine cervical cancer patients in Taiwan.
    Chung JF, Chen CL, Nassef Y, Shiu BH, Wang CH, Kuo FH, Hsiao YH, Yang SF, Wang PH.
    Int J Med Sci; 2022 Feb 11; 19(6):1013-1022. PubMed ID: 35813301
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The Association of MMP-11 Promoter Polymorphisms With Susceptibility to Lung Cancer in Taiwan.
    Chen GL, Wang SC, Huang WC, Chang WS, Tsai CW, Li HT, Shen TC, Hsia TC, Bau DT.
    Anticancer Res; 2019 Oct 11; 39(10):5375-5380. PubMed ID: 31570432
    [Abstract] [Full Text] [Related]

  • 16. Association of Fibroblast Growth Factor Receptor 4 Genetic Polymorphisms With the Development of Uterine Cervical Cancer and Patient Prognosis.
    Chen TH, Yang SF, Liu YF, Lin WL, Han CP, Wang PH.
    Reprod Sci; 2018 Jan 11; 25(1):86-93. PubMed ID: 28378614
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Interleukin-10 -1082 gene polymorphism and susceptibility to cervical cancer among Japanese women.
    Matsumoto K, Oki A, Satoh T, Okada S, Minaguchi T, Onuki M, Ochi H, Nakao S, Sakurai M, Abe A, Hamada H, Yoshikawa H.
    Jpn J Clin Oncol; 2010 Nov 11; 40(11):1113-6. PubMed ID: 20558465
    [Abstract] [Full Text] [Related]

  • 19. Correlation of chitinase 3-like 1 single nucleotide polymorphisms and haplotypes with uterine cervical cancer in Taiwanese women.
    Lin YS, Liu YF, Chou YE, Yang SF, Chien MH, Wu CH, Chou CH, Cheng CW, Wang PH.
    PLoS One; 2014 Nov 11; 9(9):e104038. PubMed ID: 25203433
    [Abstract] [Full Text] [Related]

  • 20. Tumoral and stromal expression of MMP-2, MMP-9, MMP-14, TIMP-1, TIMP-2, and VEGF-A in cervical cancer patient survival: a competing risk analysis.
    Azevedo Martins JM, Rabelo-Santos SH, do Amaral Westin MC, Zeferino LC.
    BMC Cancer; 2020 Jul 15; 20(1):660. PubMed ID: 32669083
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.